• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Harmony Biosciences Holdings, Inc. - Common Stock (NQ:HRMY)

    36.70 -0.05 (-0.14%)
    Streaming Delayed Price Updated: 10:39 AM EST, Jan 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 59,098
    Open 36.64
    Bid (Size) 36.66 (200)
    Ask (Size) 36.73 (200)
    Prev. Close 36.75
    Today's Range 36.55 - 37.01
    52wk Range 25.52 - 40.93
    Shares Outstanding 57,031,297
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Harmony Biosciences Holdings (NASDAQ:HRMY) Presents a Compelling Value and Quality Investment Case ↗
    Via Chartmill
    News headline image
    Rhythm Pharmaceuticals Faces Gravity: FDA Delays and Valuation Pressures Cool 2025’s Biotech Darling
    As the final trading days of 2025 wind down, Rhythm Pharmaceuticals (Nasdaq: RYTM) finds itself at a critical crossroads. After a meteoric rise that saw the stock gain over 100% through the first three... 
    Via MarketMinute
    Topics ETFs Economy World Trade

    Performance

    YTD
    -1.8%
    -1.8%
    1 Month
    -5.7%
    -5.7%
    3 Month
    +38.0%
    +38.0%
    6 Month
    +13.8%
    +13.8%
    1 Year
    +6.4%
    +6.4%

    More News

    Read More
    News headline image
    Harmony Biosciences Holdings (NASDAQ:HRMY) Emerges as a Prime Growth at a Reasonable Price (GARP) Candidate ↗
    Via Chartmill
    News headline image
    Beacon Biosignals Announces Partnership with Harmony Biosciences to Advance Objective Clinical Endpoints in Hypersomnia Conditions Through Quantitative EEG
    From Beacon Biosignals
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Preview For Harmony Biosciences ↗
    Via Benzinga
    News headline image
    Harmony Biosciences Holdings (NASDAQ:HRMY) Presents a Compelling Value Investment Case ↗
    Via Chartmill
    News headline image
    Harmony Biosciences Presents Clinically Meaningful Open-Label Extension Study Effectiveness Data for EPX-100 in Dravet Syndrome
    From Harmony Biosciences Holdings, Inc.
    Via Business Wire
    News headline image
    Harmony Biosciences to Present New Open-Label Extension Data from Phase 3 ARGUS Trial at the 2025 American Epilepsy Society Annual Meeting
    From Harmony Biosciences Holdings, Inc.
    Via Business Wire
    News headline image
    Harmony Biosciences Holdings (NASDAQ:HRMY) Presents a Compelling Case for Growth at a Reasonable Price ↗
    Via Chartmill
    Harmony Biosciences Raises Full-Year Revenue Guidance Ahead Of Earnings: Why Are Wakix Franchise Numbers Crucial? ↗
    Via Stocktwits
    News headline image
    Harmony Biosciences Announces Positive Results From the Pivotal Bioequivalence Study for Pitolisant Gastro-Resistant Formulation
    From Harmony Biosciences Holdings, Inc.
    Via Business Wire
    News headline image
    Harmony Biosciences Announces Initiation of First-In-Human Study With Potential Best-In-Class Orexin 2 Receptor Agonist (BP1.15205) for Central Disorders of Hypersomnolence
    From Harmony Biosciences Holdings, Inc.
    Via Business Wire
    News headline image
    Harmony Biosciences to Participate in Upcoming Investor Conferences
    From Harmony Biosciences
    Via Business Wire
    News headline image
    Harmony Biosciences Holdings (NASDAQ:HRMY) Appears Undervalued with Strong Fundamentals ↗
    Via Chartmill
    News headline image
    Harmony Biosciences Holdings (NASDAQ:HRMY) Beats Q3 2025 Estimates Despite Muted Market Reaction ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Harmony Biosciences Reports Strong Q3 2025 Financial Results; Recently Raised 2025 Revenue Guidance to $845-$865M
    From Harmony Biosciences Holdings, Inc.
    Via Business Wire
    News headline image
    Harmony Biosciences Holdings (NASDAQ:HRMY): A Prime GARP Investment with Strong Growth and a Reasonable Price ↗
    Via Chartmill
    News headline image
    Q3 2025 Earnings Season: A Market Navigating AI's Ascent Amidst Economic Shifts
    Via MarketMinute
    Topics Artificial Intelligence Economy Fraud
    News headline image
    Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue Guidance
    From Harmony Biosciences Holdings, Inc.
    Via Business Wire
    News headline image
    Harmony Biosciences Holdings (NASDAQ:HRMY) Presents a Compelling Undervalued Investment Case ↗
    Via Chartmill
    News headline image
    Harmony Biosciences Holdings (NASDAQ:HRMY): A Growth Stock with a Promising Technical Setup ↗
    Via Chartmill
    News headline image
    Top 3 Health Care Stocks That Are Preparing To Pump In Q4 ↗
    Via Benzinga
    News headline image
    Harmony Biosciences Holdings (NASDAQ:HRMY) Presents an 'Affordable Growth' Opportunity ↗
    Via Chartmill
    News headline image
    Deep Dive Into Harmony Biosciences Hldgs Stock: Analyst Perspectives (6 Ratings) ↗
    Via Benzinga

    Frequently Asked Questions

    Is Harmony Biosciences Holdings, Inc. - Common Stock publicly traded?
    Yes, Harmony Biosciences Holdings, Inc. - Common Stock is publicly traded.
    What exchange does Harmony Biosciences Holdings, Inc. - Common Stock trade on?
    Harmony Biosciences Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Harmony Biosciences Holdings, Inc. - Common Stock?
    The ticker symbol for Harmony Biosciences Holdings, Inc. - Common Stock is HRMY on the Nasdaq Stock Market
    What is the current price of Harmony Biosciences Holdings, Inc. - Common Stock?
    The current price of Harmony Biosciences Holdings, Inc. - Common Stock is 36.70
    When was Harmony Biosciences Holdings, Inc. - Common Stock last traded?
    The last trade of Harmony Biosciences Holdings, Inc. - Common Stock was at 01/06/26 10:39 AM ET
    What is the market capitalization of Harmony Biosciences Holdings, Inc. - Common Stock?
    The market capitalization of Harmony Biosciences Holdings, Inc. - Common Stock is 2.09B
    How many shares of Harmony Biosciences Holdings, Inc. - Common Stock are outstanding?
    Harmony Biosciences Holdings, Inc. - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.